Telangana DCA Made 54 Seizures Worth Rs 19.35 Lakh In September

Hyderabad: In a major crackdown, the Telangana Drugs Control Administration (DCA) conducted 54 seizures in September, confiscating medicine stocks worth Rs 19.35 lakh.

Of these, 26 cases involved quacks engaged in unlicensed stocking and sale of drugs, while 14 relate to drugs being falsely marketed as food products or nutraceuticals. Additionally, nine raids targeted unlicensed medical shops and godowns, three focused on expired drugs, and one each involved licensed manufacturing violations and banned drugs.

Among the key raids are an operation that took place on September 4, when DCA officials seized medicines worth ₹ 4 lakh from an unlicensed godown in Sangareddy. Later, on September 18, the DCA busted an illegal sale of steroid drugs intended for gym-goers involved in bodybuilding in Hyderabad. Authorities seized steroid medicines worth ₹2 lakh, which were being sold without a valid drug licence.

The Telangana Drugs Control Administration issues drug licences to medical shops and pharmacies under the Drugs and Cosmetics Act, and selling or stocking drugs without a licence can result in imprisonment of up to five years, a release stated.

A review of the DCA’s operations from January 1 to September 30 reveals that during this period, 132 cases were booked for misleading advertisements, 92 cases targeted quacks involved in unlicensed drug sales, and 72 cases were related to price violations under the Drugs (Prices Control) Order. Other cases included 49 for unlicensed drug manufacturing, 34 for marketing drugs as food products or nutraceuticals, six for spurious drug rackets, five for unlicensed cosmetic manufacturing, three for banned drug sales, and one case involving misbranded cosmetics.

Related Posts

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Mastermind of India’s massive codeine cough syrup racket skips ED summons- what’s next for Shubham Jaiswal? With arrest warrants, Red Corner Notices, and cross-border drug links, the investigation could expose…

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Gujarat based Senores Pharmaceuticals Ltd on Monday, December 15, announced that it has entered into a share purchase agreement to acquire a 100% equity stake in Apnar Pharma Private Ltd.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Aytu BioPharma launches depression drug EXXUA in U.S. market

Aytu BioPharma launches depression drug EXXUA in U.S. market

Delhi govt carries out 27 raids against fake medicine

Delhi govt carries out 27 raids against fake medicine

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

ITS in AMTZ, 70 Countries participated for Future of Health Technology

ITS in AMTZ, 70 Countries participated for Future of Health Technology